Vint Cerf speaks on stage at The 23rd Annual Webby Awards on May 13, 2019 in New York City. Noam Galai/Getty Images for Webby Awards Vint Cerf retired from Google on July 7 after 21 years as the ...
An analysis published today by independent researchers does the work the advisors neglected to do before the vote and, in ...
Newspoint on MSN
UPESSC has revised the Assistant Teacher recruitment exam pattern; questions worth 150 marks will now be asked.
UP Assistant Teacher Recruitment Exam 2025: There is a major update for candidates applying for the Assistant Teacher ...
IRSA offers a rare combination of high-quality Argentine real estate assets, a dominant market position, and a 9% dividend ...
Shareholders who held ARS Pharmaceuticals (NASDAQ: SPRY) stock watched the value drop more than 23% in after-hours trading on June 24, 2026, after the Company disclosed that Neffy® received no new ...
The Cool Down on MSN
Former federal workers and a nonprofit revive Climate.gov, the US site shut down by Trump cuts
"Trusted climate information should not disappear when politics change." ...
NEWMARKET, Ontario, May 06, 2026 (GLOBE NEWSWIRE) -- AirBoss of America Corp. (TSX: BOS) (OTCQX: ABSSF) (the “Company” or “AirBoss”) today announced its first quarter 2026 results. The Company's ...
Earnings call Banco Macro delivered a strong Q1 2026, with net income up 28% sequentially and 131% YoY, and adjusted ROE of 10.9% (11.6% reported). Management maintained full-year guidance for 42% ...
Leaders detailed real-world neffy use data, stating approximately "90% of patients experiencing anaphylaxis are effectively treated with just a single dose, consistent with published results for ...
Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.
MOSCOW, March 31 (Reuters) - Russia's largest oil producer, Rosneft (ROSN.MM), opens new tab, said on Tuesday that its 2025 net income declined by 73% to 293 billion roubles ($3.60 billion) due to ...
I first covered ARS Pharmaceuticals, Inc. (SPRY) for Seeking Alpha in September 2024, issuing stock with a Buy rating shortly after its product candidate, Neffy, a nasal spray, was approved for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results